Psychometric evaluation of ADAS-Cog and NTB for measuring drug response
Author:
Affiliation:
1. AstraZeneca R&D; Södertälje Sweden
2. AstraZeneca R&D; Cambridge MA USA
3. AstraZeneca R&D; Wilmington DE USA
4. CogState; New Haven CT USA
5. Department of Statistics; Stockholm University; Stockholm Sweden
Publisher
Wiley
Subject
Neurology (clinical),Neurology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ane.12153/fullpdf
Reference29 articles.
1. Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study;Frölich;J Alzheimers Dis,2011
2. Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study;Gold;Dement Geriatr Cogn Disord,2010
3. CERAD-neuropsychological battery in screening mild Alzheimer's disease;Sotaniemi;Acta Neurol Scand,2012
4. The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy;Mohs;Psychopharmacol Bull,1983
5. A new rating scale for Alzheimer's disease;Rosen;Am J Psychiatry,1984
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intensive assessment of executive functions derived from performance in cognitive training games;iScience;2023-06
2. State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS‐Cog) in mild Alzheimer's disease;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2023-01
3. Effect of the Mediterranean diet and probiotic supplementation in the management of mild cognitive impairment: Rationale, methods, and baseline characteristics;Frontiers in Nutrition;2022-12-08
4. Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research;Translational Psychiatry;2022-11-17
5. Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease;Alzheimer's & Dementia;2022-09-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3